litlas
Log inCreate account

Linong Ji

Active 2000–2026

219
Papers
21,462
Citations
72
h-index
189
i10-index

Citations

Citations per year for Linong Ji1987: 1 citations2001: 3 citations2002: 7 citations2003: 3 citations2004: 2 citations2005: 3 citations2006: 2 citations2007: 2 citations2008: 1 citations2010: 19 citations2011: 53 citations2012: 49 citations2013: 84 citations2014: 94 citations2015: 100 citations2016: 140 citations2017: 132 citations2018: 175 citations2019: 618 citations2020: 985 citations2021: 961 citations2022: 833 citations2023: 618 citations2024: 1,208 citations2025: 750 citations2026: 44 citations1988–2000: no citations, so these years are not shown2009: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,370 citing papers, 21.2% of this breakdownUnited States: 1,729 citing papers, 15.4% of this breakdownUnited Kingdom: 743 citing papers, 6.6% of this breakdownItaly: 442 citing papers, 4% of this breakdownAustralia: 403 citing papers, 3.6% of this breakdownGermany: 338 citing papers, 3% of this breakdownIndia: 323 citing papers, 2.9% of this breakdownCanada: 283 citing papers, 2.5% of this breakdownSpain: 247 citing papers, 2.2% of this breakdownDenmark: 227 citing papers, 2% of this breakdownFrance: 206 citing papers, 1.9% of this breakdownJapan: 201 citing papers, 1.8% of this breakdown
0%21.2%Other 32.9%

Institutions

Fields

  • Medicine71.6%
  • Biochemistry, Genetics and Molecular Biology19.5%
  • Health Professions2%
  • Neuroscience1.2%
  • Nursing1%
  • Psychology0.7%
  • Other4%

Topics

  • Diabetes Treatment and Management7.8%
  • Diabetes, Cardiovascular Risks, and Lipoproteins5.5%
  • Diabetes Management and Research4.9%
  • Gut microbiota and health3.7%
  • Diabetes and associated disorders3.5%
  • Pancreatic function and diabetes3.3%
  • Other71.3%

Coauthors

All papers

Open in search
  1. Diagnosis and Management of Prediabetes

    Authors: Justin B. Echouffo‐Tcheugui, Leigh Perreault, Linong Ji, Sam Dagogo‐Jack - JAMA 2023 cited by 435

  2. Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance

    Authors: Xiuying Zhang, Dongqian Shen, Zhiwei Fang, Zhuye Jie, Xinmin Qiu, Chunfang Zhang, Yingli Chen, Linong Ji - PLoS ONE 2013 cited by 966

  3. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

    Authors: David C. Klonoff, Jing Wang, David Rodbard, Michael A. Kohn, Chengdong Li, Dorian Liepmann, David Kerr, David Ahn, Anne L. Peters, Guillermo E. Umpierrez, Jane Jeffrie Seley, Nicole Y. Xu, Kevin T. Nguyen, Gregg D. Simonson, Michael S. D. Agus, Mohammed E. Al‐Sofiani, Gustavo Armaiz-Peña, Timothy S. Bailey, Ananda Basu, Tadej Battelino, Sewagegn Yeshiwas, Pierre‐Yves Benhamou, B. Wayne Bequette, Thomas Blevins, Marc D. Breton, Jessica R. Castle, J. Geoffrey Chase, Kong Y. Chen, Pratik Choudhary, Mark A. Clements, Kelly L. Close, Curtiss B. Cook, Thomas Danne, Francis J. Doyle, Angela Drincic, Kathleen Dungan, Steven V. Edelman, Niels Ejskjær, Juan Espinoza, G. Alexander Fleming, Gregory P. Forlenza, Guido Freckmann, Rodolfo J. Galindo, Ana María Gómez, Hanna A. Gutow, Lutz Heinemann, Irl B. Hirsch, Thanh D. Hoang, Roman Hovorka, Johan Jendle, Linong Ji, Shashank Joshi, Michaël Joubert, Suneil K. Koliwad, Rayhan Lal, M. Cecilia Lansang, Wei-An Lee, Lalantha Leelarathna, Lawrence A. Leiter, Marcus Lind, Michelle L. Litchman, Julia K. Mader, Katherine Mahoney, Boris Mankovsky, Umesh Masharani, Nestoras Mathioudakis, Alexander Yur'evich Mayorov, Jordan Messler, Joshua D. Miller, Viswanathan Mohan, James H. Nichols, Kirsten Nørgaard, David N. O’Neal, Francisco J. Pasquel, Athena Philis‐Tsimikas, Thomas R. Pieber, Moshe Phillip, William H. Polonsky, Rodica Pop‐Busui, Gerry Rayman, Eun‐Jung Rhee, Steven J. Russell, Viral N. Shah, Jennifer L. Sherr, Koji Sode, Elias K. Spanakis, Deborah J. Wake, Kayo Waki, Amisha Wallia, Melissa E. Weinberg, Howard Wolpert, Eugene E. Wright, Mihail Zilbermint, Boris Kovatchev - Journal of Diabetes Science and Technology 2022 cited by 276

  4. Standards of medical care for type 2 diabetes in China 2019

    Authors: Weiping Jia, Jianping Weng, Dalong Zhu, Linong Ji, Juming Lu, Zhiguang Zhou, Dajin Zou, Lixin Guo, Qiuhe Ji, Li Chen, Liming Chen, Jingtao Dou, Xiaohui Guo, Hongyu Kuang, Ling Li, Qifu Li, Xiaoying Li, Jing Liu, Xingwu Ran, Lixin Shi, Guangyao Song, Xinhua Xiao, Liyong Yang, Zhigang Zhao, On behalf of Chinese Diabetes Society - Diabetes/Metabolism Research and Reviews 2019 cited by 763

  5. Sex- and age-related trajectories of the adult human gut microbiota shared across populations of different ethnicities

    Authors: Xiuying Zhang, Huanzi Zhong, Yufeng Li, Zhun Shi, Huahui Ren, Zhe Zhang, Xianghai Zhou, Shanmei Tang, Xueyao Han, Yuxiang Lin, Fangming Yang, Dan Wang, Chao Fang, Zuodi Fu, Lianying Wang, Shida Zhu, Yong Hou, Xun Xu, Huanming Yang, Jian Wang, Karsten Kristiansen, Junhua Li, Linong Ji - Nature Aging 2021 cited by 245

  6. Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial

    Authors: Johannes F.E. Mann, Peter Rossing, George L. Bakris, Nicolas Belmar, Heidrun Bosch‐Traberg, Robert S. Busch, David M. Charytan, Samy Hadjadj, Pieter Gillard, José Luis Górriz, Thomas Idorn, Linong Ji, Kenneth W. Mahaffey, Vlado Perkovic, Søren Rasmussen, Roland E. Schmieder, Richard E. Pratley, Katherine R. Tuttle - Nature Medicine 2024 cited by 154

  7. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses

    Authors: Natalie Nanayakkara, Andrea J. Curtis, Stéphane Héritier, Adelle M. Gadowski, Meda E. Pavkov, Timothy Kenealy, David R. Owens, Rebecca Thomas, Soon H Song, Jencia Wong, Juliana C.N. Chan, Andrea O. Y. Luk, Giuseppe Penno, Linong Ji, Viswanathan Mohan, Anandakumar Amutha, Pedro Romero‐Aroca, Danijela Gašević, Dianna J. Magliano, Helena Teede, John Chalmers, Sophia Zoungas - Diabetologia 2020 cited by 374

  8. A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity

    Authors: Linong Ji, Hongwei� Jiang, Zhifeng Cheng, Wei Qiu, Lin Liao, Yawei Zhang, Xiaoli Li, Shuguang Pang, Lihui Zhang, Liming Chen, Tao Yang, Li Yan, Shen Qu, Jie Wen, Jieyu Gu, Huan Deng, Yanqi Wang, Li Li, Han Han‐Zhang, Qingyang Ma, Lei Qian - Nature Communications 2023 cited by 95

  9. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations

    Authors: Xiantong Zou, Xianghai Zhou, Zhanxing Zhu, Linong Ji - The Lancet Diabetes & Endocrinology 2018 cited by 266

  10. Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial

    Authors: Leili Gao, Byung‐Wan Lee, Manoj Chawla, Joshua Kim, Li Huo, Liying Du, Yan Huang, Linong Ji - Nature Medicine 2023 cited by 95

  11. Prevalence of Diabetes among Men and Women in China

    Authors: Wenying Yang, Juming Lu, Jianping Weng, Weiping Jia, Linong Ji, Jianzhong Xiao, Zhongyan Shan, Jie Liu, Haoming Tian, Qiuhe Ji, Dalong Zhu, Jiapu Ge, Lixiang Lin, Li Chen, Xiaohui Guo, Zhigang Zhao, Qiang Li, Zhiguang Zhou, Guangliang Shan, Jiang He - New England Journal of Medicine 2010 cited by 3,055

  12. Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

    Authors: Bo Zhang, Zhifeng Cheng, Ji Chen, Xin Zhang, Dexue Liu, Hongwei� Jiang, Guoqing Ma, Xiaoyun Wang, Shenglian Gan, Juan Sun, Ping Jin, Jianjun Yi, Bimin Shi, Jianhua Ma, Shandong Ye, Guixia Wang, Linong Ji, Xuejiang Gu, Ting Yu, Pei An, Huan Deng, Haoyu Li, Li Li, Qingyang Ma, Lei Qian, Wenying Yang - Diabetes Care 2023 cited by 72

  13. Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis

    Authors: Feng Sun, Shanshan Wu, Shuxia Guo, Kai Yu, Zhirong Yang, Lishi Li, Yuan Zhang, Xiaochi Quan, Linong Ji, Siyan Zhan - Diabetes Research and Clinical Practice 2015 cited by 301

  14. New insights into the treatment of obesity

    Authors: Matthias Blüher, Mohini Aras, Louis J. Aronne, Rachel L. Batterham, Francesco Giorgino, Linong Ji, Kirsi H. Pietiläinen, Oliver Schnell, Elena Tonchevska, John Wilding - Diabetes Obesity and Metabolism 2023 cited by 143

  15. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

    Authors: Francesco Rubino, David M. Nathan, Robert H. Eckel, Philip R. Schauer, K. G. M. M. Alberti, Paul Zimmet, Stefano Del Prato, Linong Ji, S.M. Sadikot, William H. Herman, Stephanie A. Amiel, Lee M. Kaplan, Gaspar Taroncher‐Oldenburg, David E. Cummings, Delegates of the 2nd Diabetes Surgery Summit, Nizar Albache, Rachel L. Batterham, Deepak L. Bhatt, Camilo Boza, William T. Cefalu, Ricardo V. Cohen, Anita P. Courcoulas, Seán F. Dinneen, John B. Dixon, Ele Ferrannini, Paola Fioretto, Gema Frühbeck, Michel Gagner, Richard W. Grant, Sayeed Ikramuddin, Desmond G. Johnston, Sangeeta R. Kashyap, Tracy Kelly, Tomasz Klupa, Judith Körner, Blandine Laferrère, Harold E. Lebovitz, Wei‐Jei Lee, Carel W. le Roux, Jeffrey I. Mechanick, Geltrude Mingrone, John M. Morton, Walter J. Pories, Robert E. Ratner, Gerry Rayman, Harvey J. Sugerman, Luc Van Gaal, Josép Vidal, Jianping Weng, Bruce M. Wolfe - Diabetes Care 2016 cited by 971

  16. Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial

    Authors: Linong Ji, Leili Gao, Hongwei� Jiang, Jing Yang, Lei Yu, Jie Wen, Chenghang Cai, Huan Deng, Liqi Feng, Baili Song, Qingyang Ma, Lei Qian - EClinicalMedicine 2022 cited by 72

  17. Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial

    Authors: Lihui Zhang, Yunliang Zhang, Sheng'ai Shen, Xueying Wang, Luling Dong, Qiuyun Li, Weidong Ren, Yufeng Li, Jianling Bai, Qiuhong Gong, Hongyu Kuang, Lin Qi, Qiang Lü, Wenli Cheng, Yanjie Liu, Shuang Yan, Dong‐Hong Wu, Hui Fang, Fang Hou, Yingju Wang, Zhixia Yang, Lian Xu, Jianling Du, Ningling Sun, Ningling Sun, Guangwei Li, Linong Ji, Guangwei Li, Sheng'ai Shen, Lihui Zhang, Luling Dong, Qiuyun Li, Weidong Ren, Yufeng Li, Qiuyun Li, Weidong Ren, Lin Qi, Qiang Lü, Wenli Cheng, Yanjie Liu, Shuang Yan, Dong‐Hong Wu, Yanjie Liu, Ningling Sun, Donghong Wu, Guangwei Li, Fang Hou, Ningling Sun, Zhixia Yang, Lian Xu, Jianling Du, Ping Tu, Su Wang, Xinhua Yin, Wen-Jia Chen, Qing He, Zhongyan Shan, Xueqin Wang, Jin-Rong Liang, Chang Liu, Yun Xie, Binhong Duan, Zhongyan Shan, Zhengnan Gao, Li Li, Lijuan Jiang, Huimin Han, Binhong Duan, Li Sun, Bo Feng, Lingling Cao, Xinfang Wang, Huimin Han, Tong Zhang, Xiaoyan Liu, Qiuhong Gong, Lingling Cao, Xinfang Wang, Xiaoping Chen, Tong Zhang, Xiaoyan Liu, Qiuhong Gong - The Lancet Diabetes & Endocrinology 2023 cited by 83

  18. Gastrointestinal Adverse Events of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

    Authors: Feng Sun, Sanbao Chai, Kai Yu, Xiaochi Quan, Zhirong Yang, Shanshan Wu, Yuan Zhang, Linong Ji, Jun Wang, Luwen Shi - Diabetes Technology & Therapeutics 2014 cited by 151

  19. Efficacy and safety of once‐weekly semaglutide versus once‐daily sitagliptin as add‐on to metformin in patients with type 2 diabetes in SUSTAIN China : A 30‐week, double‐blind, phase 3a, randomized trial

    Authors: Linong Ji, Xiaolin Dong, Yiming Li, Yufeng Li, Soo Lim, Ming Liu, Ning Zu, Søren Rasmussen, Trine Vang Skjøth, Guoyue Yuan, Freddy G. Eliaschewitz - Diabetes Obesity and Metabolism 2020 cited by 103

  20. Diabetes and obesity are the main metabolic drivers of peripheral neuropathy

    Authors: Brian C. Callaghan, Leili Gao, Yufeng Li, Xianghai Zhou, Evan L. Reynolds, Mousumi Banerjee, Rodica Pop‐Busui, Eva L. Feldman, Linong Ji - Annals of Clinical and Translational Neurology 2018 cited by 196

  21. New-Onset Diabetes in Covid-19

    Authors: Francesco Rubino, Stephanie A. Amiel, Paul Zimmet, George Alberti, Stefan R. Bornstein, Robert H. Eckel, Geltrude Mingrone, Bernhard O. Boehm, Mark E. Cooper, Zhonglin Chai, Stefano Del Prato, Linong Ji, David Hopkins, William H. Herman, Kamlesh Khunti, Jean Claude Mbanya, Éric Renard - New England Journal of Medicine 2020 cited by 828

  22. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort

    Authors: Roseanne O. Yeung, Yuying Zhang, Andrea O. Y. Luk, Wenying Yang, Leorino Sobrepeña, Kun‐Ho Yoon, S. R. Aravind, Wayne Huey‐Herng Sheu, Thy Khue Nguyen, Risa Ozaki, Chaicharn Deerochanawong, Chiu Chi Tsang, Wing-Bun Chan, Eun Gyoung Hong, Trung Quan, Yu Cheung, Nicola Brown, Su Yen Goh, Ronald C.W., M. Mukhopadhyay, Arvind Kumar Ojha, Shaibal Chakraborty, Alice P.S. Kong, Winnie Lau, Weiping Jia, Wenhui Li, Xiaohui Guo, Rongwen Bian, Jianping Weng, Linong Ji, Mercedes Reyes-dela Rosa, Ronaldo M Toledo, Thep Himathongkam, Soon-Jib Yoo, C. C. Chow, Larry L-T. Ho, Lee‐Ming Chuang, Greg Tutino, Peter C.Y. Tong, Wing‐Yee So, Troels Wolthers, Gary T.C. Ko, Greg Lyubomirsky, Juliana C.N. Chan - The Lancet Diabetes & Endocrinology 2014 cited by 302

  23. Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial

    Authors: Xiuying Zhang, Zhiwei Fang, Chunfang Zhang, Huihua Xia, Zhuye Jie, Xueyao Han, Yingli Chen, Linong Ji - Diabetes Therapy 2017 cited by 183

  24. NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?—Results From NHANES III

    Authors: Qi Huang, Xiantong Zou, Xin Wen, Xianghai Zhou, Linong Ji - Frontiers in Medicine 2021 cited by 113